IN2014MN01940A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN01940A IN2014MN01940A IN1940MUN2014A IN2014MN01940A IN 2014MN01940 A IN2014MN01940 A IN 2014MN01940A IN 1940MUN2014 A IN1940MUN2014 A IN 1940MUN2014A IN 2014MN01940 A IN2014MN01940 A IN 2014MN01940A
- Authority
- IN
- India
- Prior art keywords
- getting
- risk
- cardiovascular event
- level
- neurotensin
- Prior art date
Links
- 230000007211 cardiovascular event Effects 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 2
- 108010054321 proneurotensin Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261608376P | 2012-03-08 | 2012-03-08 | |
| EP12158678 | 2012-03-08 | ||
| EP12165057 | 2012-04-20 | ||
| PCT/EP2013/054799 WO2013132088A1 (en) | 2012-03-08 | 2013-03-08 | A method for predicting the risk of getting a cardiovascular event in a female subject |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01940A true IN2014MN01940A (enExample) | 2015-07-10 |
Family
ID=49115969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1940MUN2014 IN2014MN01940A (enExample) | 2012-03-08 | 2013-03-08 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150118236A1 (enExample) |
| EP (1) | EP2823318B1 (enExample) |
| JP (1) | JP6431373B2 (enExample) |
| CN (1) | CN103308673B (enExample) |
| IN (1) | IN2014MN01940A (enExample) |
| RU (1) | RU2652304C2 (enExample) |
| WO (1) | WO2013132088A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160097781A1 (en) * | 2014-10-01 | 2016-04-07 | Sphingotec Gmbh | Method for stratifying a female subject for hormone replacement therapy |
| RU2745751C2 (ru) * | 2015-02-27 | 2021-03-31 | Сфинготек Гмбх | Способ прогнозирования риска развития ожирения у субъекта |
| MX2020004219A (es) * | 2017-10-24 | 2020-07-22 | Sphingotec Gmbh | Selenoproteina p para prediccion de un primer evento cardiovascular. |
| CN109678958B (zh) * | 2019-01-31 | 2022-03-18 | 重庆探生科技有限公司 | 一种人NT-proBNP特异性重组羊单克隆抗体及其制备方法和应用 |
| RU2718285C1 (ru) * | 2019-05-31 | 2020-04-01 | федеральное государственное бюджетное образовательное учреждение высшего образования "Новосибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО НГМУ Минздрава России) | Способ прогнозирования риска развития инсульта у мужчин, работающих в условиях воздействия общей вибрации |
| WO2022101937A1 (en) * | 2020-11-12 | 2022-05-19 | Shah Komal | An integrated health data capture and analysis based device for evaluation, diagnosis and prognosis of heart failure |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU634716B2 (en) | 1988-08-01 | 1993-03-04 | Ciba Corning Diagnostics Corp. | Method for detection of an analyte using acridinium esters and liposomes |
| US6352862B1 (en) * | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
| EP0854934A4 (en) * | 1995-08-18 | 2000-09-06 | Donald W Landry | DETECTION OF ORGANIC COMPOUNDS BY REGULATION OF ANTIBODY CATALYZED REACTIONS |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| EP1419388B1 (en) * | 2001-08-20 | 2009-10-07 | Biosite Incorporated | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| WO2003020746A1 (en) | 2001-08-30 | 2003-03-13 | Biorexis Pharmaceutical Corporation | Modified transferrin fusion proteins |
| EP2298278B1 (en) | 2002-06-07 | 2015-11-11 | Dyax Corp. | Prevention and reduction of blood loss and inflammatory response |
| US7634360B2 (en) * | 2003-09-23 | 2009-12-15 | Prediction Sciences, LL | Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof |
| EP1675878A2 (en) | 2003-10-24 | 2006-07-05 | Avidia, Inc. | Ldl receptor class a and egf domain monomers and multimers |
| US20100028995A1 (en) | 2004-02-23 | 2010-02-04 | Anaphore, Inc. | Tetranectin Trimerizing Polypeptides |
| ES2421556T3 (es) * | 2004-06-15 | 2013-09-03 | Hoffmann La Roche | Utilización de hormonas cardíacas para diagnosticar el riesgo de sufrir complicaciones cardiovasculares como consecuencia de medicamentos cardiotóxicos |
| EP1793847A2 (en) | 2004-09-21 | 2007-06-13 | NascaCell IP GmbH | Use of microproteins as tryptase inhibitors |
| DE102005003687A1 (de) * | 2005-01-26 | 2006-07-27 | Sphingo Tec Gmbh | Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation |
| EP2231860B1 (en) | 2007-12-19 | 2011-10-05 | Affibody AB | Polypeptide derived from protein a and able to bind pdgf |
| MX359570B (es) | 2008-11-03 | 2018-10-01 | Molecular Partners Ag | Proteinas de union que inhiben la interaccion en el receptor de vegf-a. |
| EP2374003B1 (en) | 2009-01-07 | 2015-03-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment, the prognostic assessment and the detection of breast cancer |
| JP5753159B2 (ja) * | 2009-05-05 | 2015-07-22 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 内皮性機能／機能不全に関連した疾患に罹患している患者の血管作動性ホルモンに基づいた層化 |
| US9376477B2 (en) | 2009-08-27 | 2016-06-28 | Covagen Ag | IL-17 binding compounds and medical uses thereof |
| US8846414B2 (en) * | 2009-09-29 | 2014-09-30 | Advanced Liquid Logic, Inc. | Detection of cardiac markers on a droplet actuator |
| WO2011073214A2 (en) | 2009-12-14 | 2011-06-23 | Scil Proteins Gmbh | A method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands |
| JP5902679B2 (ja) | 2010-06-08 | 2016-04-13 | ピエリス アーゲーＰｉｅｒｉｓ Ａｇ | ＩＬ−４Ｒαに結合する涙液リポカリンムテイン |
-
2012
- 2012-10-08 CN CN201210520697.6A patent/CN103308673B/zh not_active Expired - Fee Related
-
2013
- 2013-03-08 IN IN1940MUN2014 patent/IN2014MN01940A/en unknown
- 2013-03-08 EP EP13708192.3A patent/EP2823318B1/en active Active
- 2013-03-08 JP JP2014560403A patent/JP6431373B2/ja not_active Expired - Fee Related
- 2013-03-08 US US14/383,425 patent/US20150118236A1/en not_active Abandoned
- 2013-03-08 WO PCT/EP2013/054799 patent/WO2013132088A1/en not_active Ceased
- 2013-03-08 RU RU2014140430A patent/RU2652304C2/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2823318A1 (en) | 2015-01-14 |
| WO2013132088A4 (en) | 2013-11-07 |
| WO2013132088A1 (en) | 2013-09-12 |
| JP6431373B2 (ja) | 2018-11-28 |
| CN103308673B (zh) | 2017-05-31 |
| US20150118236A1 (en) | 2015-04-30 |
| RU2652304C2 (ru) | 2018-04-25 |
| JP2015511007A (ja) | 2015-04-13 |
| CN103308673A (zh) | 2013-09-18 |
| RU2014140430A (ru) | 2016-04-27 |
| EP2823318B1 (en) | 2016-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN01940A (enExample) | ||
| BRPI0921754A2 (pt) | métodos para determinar a geometria de fratura de uma formação subterrânea, e para modelar parâmetros geométricos de uma fratura de formação subterrânea | |
| WO2014053466A3 (en) | System and method for assessing risk associated with a glucose state | |
| MX349561B (es) | Método para detectar nucleosomas que contienen variantes de histonas. | |
| BR112013032183A2 (pt) | sistema e método de avaliação de recursos | |
| EP4462120A3 (en) | Methods for predicting response to parp inhibitors | |
| IN2014CN04326A (enExample) | ||
| WO2013159872A8 (en) | Biomarkers for the diagnosis, prognosis, assessment and therapy stratification of syncope | |
| IN2014DN04645A (enExample) | ||
| TN2013000464A1 (en) | Biomarkers for hedgehog inhibitor therapy | |
| NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
| WO2014200912A3 (en) | Mathematical processes for determination of peptidase cleavage | |
| IL230896B (en) | Micro-rna biological markers for use in detecting the presence or risk of a lung tumor or an aggressive lung tumor | |
| WO2012135227A3 (en) | Methods and systems for assessing exposure to heavy metals | |
| FR2992620B1 (fr) | Train et procede de determination de la composition d'un tel train en securite | |
| MX2015015328A (es) | Deteccion de grietas de borde. | |
| FR2996192B1 (fr) | Procede de determination de l'etat d'usure d'une piece et d'information d'un client | |
| MX2022013471A (es) | Metodo y composiciones de deteccion y cuantificacion de acido nucleico. | |
| IN2014MN01936A (enExample) | ||
| IN2015DN01646A (enExample) | ||
| IN2014MN01937A (enExample) | ||
| HK1231512A1 (zh) | 检测样本中多种核酸的方法 | |
| FR2996250B1 (fr) | Procede d'identification et/ou de suivi de la deformation d'une piece de turbomachine | |
| GB201418613D0 (en) | Method for assessing the condition of piping and vessels | |
| WO2014023952A3 (en) | Interleukin-18 inhibitor for use in prevention and treatment of osteoarthritis |